Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of CHF 1535 NEXT DPI in Asthma
NCT01191424Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Systemic exposure to Beclometasone-17-Monopropionate. Started Oct 2010; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01191424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01191424.